Insulin Test Dubai — Fasting Insulin & HOMA-IR

Insulin resistance is a metabolic state in which body cells fail to respond normally to the hormone insulin, requiring the pancreas to secrete progressively larger amounts to achieve the same glucose-lowering effect. Over time, if the pancreas cannot sustain this compensatory hyperinsulinaemia, blood glucose rises into the prediabetic and then diabetic range. Even before glucose rises, sustained high insulin levels promote fat storage, inflammation, cardiovascular risk, hormonal disruption in women causing PCOS, and non-alcoholic fatty liver disease. Detecting insulin resistance early, when the pancreas is still compensating effectively, allows intervention before any of these downstream consequences develop.

HOMA-IR stands for Homeostatic Model Assessment of Insulin Resistance. The formula is: fasting insulin (mIU/L) x fasting glucose (mmol/L) divided by 22.5. Both values must be measured from the same fasting blood sample for the calculation to be valid. HOMA-IR values below 1.0 indicate good insulin sensitivity. Values between 1.0 and 1.9 suggest mild resistance. Values of 2.0 to 2.9 indicate moderate resistance, and values above 2.9 reflect significant resistance associated with elevated cardiometabolic risk. Population-specific thresholds may vary slightly, and interpretation should always account for clinical context.

Yes, insulin resistance is highly reversible, particularly when detected early. The most effective interventions are lifestyle-based: dietary modification reducing refined carbohydrates, added sugars, and ultra-processed foods; regular aerobic and resistance exercise; weight reduction of even 5 to 10 percent of body weight; and improved sleep quality. Metabolic interventions including metformin, GLP-1 receptor agonists, and inositol supplementation (particularly for PCOS) can further improve insulin sensitivity. Monitoring HOMA-IR over time provides an objective measure of treatment response.

Insulin resistance is present in 60 to 80 percent of women with polycystic ovarian syndrome, regardless of body weight. Elevated insulin directly stimulates ovarian theca cells to produce excess androgens including testosterone, contributing to the hyperandrogenism that causes acne, hirsutism, and irregular periods characteristic of PCOS. High insulin also suppresses sex hormone binding globulin (SHBG) production by the liver, increasing free androgen levels further. Treating insulin resistance in PCOS through lifestyle modification and metformin frequently improves menstrual regularity, reduces androgen levels, and restores fertility without the need for hormonal contraception or fertility drugs.

HbA1c and fasting glucose measure the outcome of insulin resistance (elevated blood sugar) rather than the underlying process. In the early, compensated phase of insulin resistance, the pancreas secretes more insulin to keep glucose normal. During this phase, HbA1c and fasting glucose remain entirely normal while fasting insulin and HOMA-IR are already elevated. This compensated phase can last 10 to 20 years before glucose-based tests become abnormal. By directly measuring insulin, the HOMA-IR test detects the metabolic dysfunction a decade or more earlier, when interventions are most effective.

Insulin resistance drives multiple simultaneous cardiovascular risk factors. It promotes dyslipidaemia characterised by elevated triglycerides, small dense LDL particles (the most atherogenic form), and reduced HDL cholesterol. It stimulates the liver to produce very low density lipoprotein (VLDL), worsening the lipid profile. Hyperinsulinaemia promotes arterial smooth muscle proliferation, endothelial dysfunction, and systemic inflammation measured by CRP. It contributes to hypertension through sodium retention and sympathetic nervous system activation. Together, these effects explain why insulin resistance is independently associated with a two- to threefold increase in cardiovascular events.

Yes. While insulin resistance is strongly associated with obesity, particularly central adiposity, it can affect individuals with normal body weight. This pattern, sometimes called metabolically obese normal weight (MONW) or thin fat, is particularly common in South Asian populations including many UAE residents. These individuals have normal BMI but disproportionately high visceral and intramuscular fat relative to lean mass, creating metabolic dysfunction. Fasting insulin and HOMA-IR are the only clinical tools that can detect insulin resistance in normal-weight individuals whose glucose remains completely normal.

Yes, strict fasting is essential for accurate results. Insulin levels rise rapidly after food consumption and take several hours to return to baseline. A minimum 8-hour fast is required, with 10 to 12 hours preferred. Water, plain black coffee, and medications are generally permissible unless your doctor advises otherwise. The test should be postponed if you are acutely unwell, as infection and stress raise insulin and glucose through cortisol-mediated insulin resistance, potentially elevating HOMA-IR falsely. For women, the menstrual phase does not significantly affect fasting insulin; testing can proceed at any point in the cycle.